Literature DB >> 8496306

Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans.

R C Zimmermann1, C J McDougle, M Schumacher, J Olcese, J W Mason, G R Heninger, L H Price.   

Abstract

Measurement of melatonin secretion throughout the night provides an index of net noradrenergic activity mediated by postsynaptic beta-adrenergic receptors in the pineal gland. Reduced melatonin secretion in some patients with depression might be related to reduced net noradrenergic function. However, a dysregulation in serotonin function has also been implicated in the pathophysiology of depression. The essential amino acid tryptophan is the precursor for both serotonin and melatonin production. To determine the effects of serotonin function on nocturnal melatonin secretion, eight healthy volunteers underwent active and sham tryptophan depletion in a randomized, double-blind fashion. Blood samples for melatonin and free and total tryptophan were obtained before and after the depletion. Acute tryptophan depletion decreased free and total plasma tryptophan levels to less than 20% of baseline levels. Melatonin secretion, expressed as area under the curve, was decreased in all eight subjects after tryptophan depletion when compared to sham depletion. These results suggest that reduced plasma tryptophan levels, and presumably brain serotonin concentrations, decrease nocturnal melatonin secretion in humans. Additional studies investigating the relationship between serotonin metabolism and pineal function in humans appear warranted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496306     DOI: 10.1210/jcem.76.5.8496306

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Sleep and rhythm consequences of a genetically induced loss of serotonin.

Authors:  Smaranda Leu-Semenescu; Isabelle Arnulf; Caroline Decaix; Fathi Moussa; Fabienne Clot; Camille Boniol; Yvan Touitou; Richard Levy; Marie Vidailhet; Emmanuel Roze
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 2.  Melatonin, sleep, aging, and the health protection branch.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

3.  Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?

Authors:  Joanna Dulce Favacho de Oliveira Torres; Ricardo de Souza Pereira
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

4.  Relationship of morningness-eveningness questionnaire score to melatonin and sleep timing, body mass index and atypical depressive symptoms in peri- and post-menopausal women.

Authors:  Charles John Meliska; Luis Fernando Martínez; Ana María López; Diane Lynn Sorenson; Sara Nowakowski; Barbara Lockhart Parry
Journal:  Psychiatry Res       Date:  2011-01-14       Impact factor: 3.222

Review 5.  Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

6.  Serotonergic mechanisms of cocaine effects in humans.

Authors:  S C Aronson; J E Black; C J McDougle; B E Scanley; P Jatlow; T R Kosten; G R Heninger; L H Price
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

7.  Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: a new biomarker.

Authors:  Shoji Yano; Kathryn Moseley; Colleen Azen
Journal:  J Pediatr       Date:  2012-11-16       Impact factor: 4.406

8.  Dietary factors and fluctuating levels of melatonin.

Authors:  Katri Peuhkuri; Nora Sihvola; Riitta Korpela
Journal:  Food Nutr Res       Date:  2012-07-20       Impact factor: 3.894

9.  Sentra PM (a Medical Food) and Trazodone in the Management of Sleep Disorders.

Authors:  William E Shell; Lawrence A May; Debora H Bullias; Stephanie L Pavlik; David S Silver
Journal:  J Cent Nerv Syst Dis       Date:  2012-04-23

10.  Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS).

Authors:  Federica Murgia; Antonella Gagliano; Marcello G Tanca; Noga Or-Geva; Aran Hendren; Sara Carucci; Manuela Pintor; Francesca Cera; Fausto Cossu; Stefano Sotgiu; Luigi Atzori; Alessandro Zuddas
Journal:  Front Neurosci       Date:  2021-05-28       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.